Proteomics International Laboratories Ltd

ASX:PIQ Stock Report

Market Cap: AU$134.3m

Proteomics International Laboratories Past Earnings Performance

Past criteria checks 0/6

Proteomics International Laboratories's earnings have been declining at an average annual rate of -30.2%, while the Life Sciences industry saw earnings growing at 20.8% annually. Revenues have been growing at an average rate of 5.7% per year.

Key information

-30.2%

Earnings growth rate

-21.6%

EPS growth rate

Life Sciences Industry Growth19.7%
Revenue growth rate5.7%
Return on equity-115.2%
Net Margin-194.6%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Most Shareholders Will Probably Find That The CEO Compensation For Proteomics International Laboratories Limited (ASX:PIQ) Is Reasonable

Nov 16
Most Shareholders Will Probably Find That The CEO Compensation For Proteomics International Laboratories Limited (ASX:PIQ) Is Reasonable

Calculating The Fair Value Of Proteomics International Laboratories Limited (ASX:PIQ)

Sep 29
Calculating The Fair Value Of Proteomics International Laboratories Limited (ASX:PIQ)

We're Hopeful That Proteomics International Laboratories (ASX:PIQ) Will Use Its Cash Wisely

May 10
We're Hopeful That Proteomics International Laboratories (ASX:PIQ) Will Use Its Cash Wisely

Here's Why We Think Proteomics International Laboratories Limited's (ASX:PIQ) CEO Compensation Looks Fair for the time being

Nov 17
Here's Why We Think Proteomics International Laboratories Limited's (ASX:PIQ) CEO Compensation Looks Fair for the time being

Is Proteomics International Laboratories (ASX:PIQ) In A Good Position To Invest In Growth?

Aug 09
Is Proteomics International Laboratories (ASX:PIQ) In A Good Position To Invest In Growth?

We Think Proteomics International Laboratories (ASX:PIQ) Can Afford To Drive Business Growth

Oct 20
We Think Proteomics International Laboratories (ASX:PIQ) Can Afford To Drive Business Growth

We're Not Worried About Proteomics International Laboratories' (ASX:PIQ) Cash Burn

May 31
We're Not Worried About Proteomics International Laboratories' (ASX:PIQ) Cash Burn

Revenue & Expenses Breakdown

How Proteomics International Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:PIQ Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 233-660
30 Sep 233-660
30 Jun 233-660
31 Mar 233-660
31 Dec 224-660
30 Sep 223-560
30 Jun 223-550
31 Mar 223-550
31 Dec 213-450
30 Sep 213-440
30 Jun 213-340
31 Mar 213-340
31 Dec 202-240
30 Sep 203-230
30 Jun 203-230
31 Mar 203-230
31 Dec 193-221
30 Sep 193-231
30 Jun 193-231
31 Mar 193-231
31 Dec 183-230
30 Sep 182-220
30 Jun 182-120
31 Mar 182-120
31 Dec 172-120
30 Sep 172-120
30 Jun 172-120
31 Mar 172-120
31 Dec 162-120
30 Sep 162-120
30 Jun 161-120
31 Mar 161-220
31 Dec 151-220
30 Sep 151-210
30 Jun 151-110
30 Jun 141010

Quality Earnings: PIQ is currently unprofitable.

Growing Profit Margin: PIQ is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PIQ is unprofitable, and losses have increased over the past 5 years at a rate of 30.2% per year.

Accelerating Growth: Unable to compare PIQ's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PIQ is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-1.7%).


Return on Equity

High ROE: PIQ has a negative Return on Equity (-115.15%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.